ASXL1 and acute myeloid leukemia: Although ASXL1 and TP53 mutations could classify distinct subgroups of AML-MRC, patients without any of these mutations still represent a heterogeneous group of AML-MRC harboring different morphological, cytogenetic and molecular features.